Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Hepa/Biliary Other
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Hepa/Biliary Other
    Fatty Liver Disease May Raise Heart Disease Risk in Overweight and Obese Children - (DGNews)
    Sirolimus Increases Graft Survival in Orthotopic Liver Transplant Recipients: Presented at ATC - (DGDispatch)
    Researchers Pinpoint Risk Factors for Infections Post-Liver Transplantation - (DGNews)
    Hepatitis C-Positive Patients Treated With Rituximab Are at Increased Risk of Liver Toxicities: Presented at IM - (DGDispatch)
    Does this patient have bacterial peritonitis or portal hypertension? How do I perform a paracentesis and analyze the results? - (JAMA)

    News archive

     Recent webcasts/CME - Hepa/Biliary Other

    Webcasts/CME archive

     Recent cases - Hepa/Biliary Other
      An Atypical Presentation of Cystic Fibrosis: A Case Report
      Middle Bile Duct Cancer with Portal Vein Tumor Thrombus
      Co-Existence of a Giant Splenic Hemangioma and Multiple Hepatic Hemangiomas and the Potential Association With the Use of Oral Contraceptives: A Case Report
      Intrahepatic Cholestasis in Subclinical and Overt Hyperthyroidism: Two Case Reports
      Peliosis and Gummatous Syphilis of the Liver: A Case Report

      Cases archive
        




      my personal edition > hepa/biliary other > news
      divider

        E-Mail this DGReview to a colleague

      DGReview


      Liver Tests Fail to Measure Up to CPS II in Biliary Cirrhosis

      A DGReview of :"Quantitative testing of liver function compared to prognostic scores in patients with primary biliary cirrhosis"
      Liver

      06/14/2002
      By Mark Pownall


      The best method of measuring the progress of primary biliary cirrhosis is the established Christiansen prognosis score (CPS), a comparison of different measures has concluded.

      But, the comparison also indicates that the second version of the prognosis score, CPS II, is a better measure of disease progression.

      A proposed alternative method of assessing prognosis using quantitative tests of liver function, did not appear to be as sensitive to change as CPS II.

      Researchers from the University of Erlangen-Nuernberg in Germany followed 34 patients with primary biliary cirrhosis over two years. At the beginning of the study, the patients were investigated with CPS I and II, and the Mayo prognosis score. They also had serum levels of a surrogate marker for hepatic fibrogenesis (PIINP) measured, as well as other parameters relevant to primary biliary cirrhosis, and quantitative tests of liver function. The patients also underwent histological staging of their condition.

      The liver tests carried out included the aminopyrine breath test, galactose elimination capacity, and sorbitol and indocyanine green clearance. The tests were repeated after two years. Bilirubin, serum IgM and PIINP were raised at both times of measurement, but albumin and prothrombin levels remained normal.

      Clinical findings of ascites, cirrhosis and central cholestasis were worse after two years, as was histological staging. Despite this progression of disease, the liver tests CPS I and Mayo scores barely changed.

      The researchers concluded that the quantitative liver tests and the measurement of the fibrogenesis marker added nothing to assessment of progression of the biliary cirrhosis over two years, and that CPS II is better for measurement of prognosis in the short term.
      Liver 2002; 22(2): 159-165. "Quantitative testing of liver function compared to prognostic scores in patients with primary biliary cirrhosis"

      E-Mail this DGReview to a colleague   To print, use this version






      All contents Copyright (c) 1995-2008 Doctor's Guide Publishing Limited. All rights reserved.



      The NTK initiative. Physicians helping physicians identify Need-To-Know science
         Feedback
      Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
      Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
      1
      2
      3
      4
      5
      6
      7
      Send